natgillin/translations-raw huggingface dataset:
Pritor 20 mg tabletter Pakningsstørrelser: Blister med 14, 28, 30, 56, 90 eller 98 tabletter.
Pritor 20 mg tablets Pack sizes: Blister with 14, 28, 30, 56, 90 or 98 tablets.
Du skal opbevare Pritor i den originale yderpakning for at beskytte tabletterne mod fugt.
You should store your medicine in the original package in order to protect the tablets from moisture.
Før start af behandling med flere typer medicin, der påvirker renin-angiotensin-aldosteronsystemet bør man nøje afveje fordele og ulemper mod hinanden..
Before considering the concomitant use of medicinal products that affect the renin-angiotensinaldosterone system, the benefit risk ratio should be evaluated.
• Hvis du samtidig tager en ACE-hæmmer eller aliskiren (se også information under overskriften
• If you are taking an ACE-inhibitor or aliskiren (see also information under the headings “Do not take Pritor” and “Warnings and precautions”).
Du skal derfor tale med din læge om eventuelt at få ændret doseringen af din medicin.
You should consult with your doctor if you need to adjust the dose of your other medicine while taking Pritor.
MINDSTEKRAV TIL MÆRKNING PÅ BLISTER ELLER STRIP Unit dose-blister (28 x 1 tablet) og andre blisters bortset fra 7 styk
MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS Unit dose blister (28 x 1 tablets pack) or any non 7 count blister
Dette er bekræftet ved målinger, der blev foretaget på tidspunktet for maksimal effekt og umiddelbart forud for den næste dosis (trough/peak ratio var over 80% efter dosering af 40 mg og 80 mg telmisartan i alle placebokontrollerede kliniske studier).
This is confirmed by trough to peak ratios consistently above 80 % seen after doses of 40 and 80 mg of telmisartan in placebo controlled clinical studies.
Børn og unge Børn og unge under 18 år bør ikke behandles med Pritor.
Children and adolescents The use of Pritor in children and adolescents up to the age of 18 years is not recommended.
Specielt efter den første dosis af Pritor kan der forekomme symptomatisk hypotension hos patienter, som har for lavt volumen i blodbanen eller natriummangel på grund af kraftig diuretisk behandling, saltfattig diæt, diarré eller opkastning.
Symptomatic hypotension, especially after the first dose of Pritor, may occur in patients who are volume and/or sodium depleted by vigorous diuretic therapy, dietary salt restriction, diarrhoea, or vomiting.
Fremstiller Bayer AG
Manufacturer Bayer AG
• Vanddrivende medicin i høje doser kan føre til overdrevent tab af kropsvæske og for lavt blodtryk (hypotension).
• Diuretics ('water tablets'), especially if taken in high doses together with Pritor, may lead to excessive loss of body water and low blood pressure (hypotension).
Opbevares i original emballage for at beskytte mod fugt.
Store in the original package in order to protect from moisture.
Abdominalsmerter, diare, dyspepsi, flatulens, opkastning
Abdominal pain, diarrhoea, dyspepsia, flatulence, vomiting Dry mouth, stomach discomfort, dysgeusia
Til behandling af forhøjet blodtryk er den normale dosering af Pritor til kontrol af blodtrykket i 24 timer én tablet á 40 mg én gang daglig.
For treatment of high blood pressure, the usual dose of Pritor for most patients is one 40 mg tablet once a day to control blood pressure over the 24-hour period.
• Nyresygdom eller du har fået en nyretransplantation
• Kidney disease or kidney transplant.
I prækliniske sikkerhedsforsøg i normotensive dyr med doser, der gav en eksponering sammenlignelig med den i det klinisk terapeutiske område, fandt man en reduktion af røde blodcelleparametre (erytrocyter, hæmoglobin, hæmatokrit), og ændringer i den renale hæmodynamik (forhøjet BUN og kreatinin) såvel som forhøjet serumkalium.
In preclinical safety studies, doses producing exposure comparable to that in the clinical therapeutic range caused reduced red cell parameters (erythrocytes, haemoglobin, haematocrit), changes in renal haemodynamics (increased blood urea nitrogen and creatinine), as well as increased serum potassium in normotensive animals.
Der var evidens for en fordel ved telmisartan i forhold til placebo i det præspecificerede sekundære sammensatte endepunkt (kardiovaskulær død, ikke-letalt myokardieinfarkt og ikke-letal apopleksi) [0,87 (95% CI 0,76-1,00; p = 0,048)].
There was evidence for a benefit of telmisartan compared to placebo in the pre-specified secondary composite endpoint of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke [0.87 (95 % CI 0.76 - 1.00, p = 0.048)].
Pritor 20 mg tabletter 3 år.
Pritor 20 mg tablets 3 years
Pritor 40 mg og 80 mg tabletter 4 år.
Pritor 40 mg and 80 mg tablets 4 years
I kontrollerede studier med hypertensionspatienter var den samlede forekomst af bivirkninger ved brug af telmisartan, sædvanligvis sammenlignelig med placebo (41,4% vs. 43,9%).
The overall incidence of adverse reactions reported with telmisartan was usually comparable to placebo (41.4 % vs 43.9 %) in controlled trials in patients treated for hypertension.
Der bør udvises forsigtighed, når Pritor bruges til patienter med let til moderat nedsat leverfunktion.
Pritor should be used only with caution in patients with mild to moderate hepatic impairment.
Hvis du har taget for meget Pritor Hvis du har taget for mange tabletter, så kontakt lægen, skadestuen eller apoteket.
If you accidentally take too many tablets, contact your doctor, pharmacist, or your nearest hospital emergency department immediately.
Behandling i andet og tredje trimester med angiotensin II-receptorantagonister kan medføre human føtotoksicitet (nedsat nyrefunktion, oligohydramnios, forsinkelse af knogledannelsen i kraniet) og neonatal toksicitet (nyresvigt, hypotension, hyperkaliæmi).
Exposure to angiotensin II receptor antagonist therapy during the second and third trimesters is known to induce human fetotoxicity (decreased renal function, oligohydramnios, skull ossification retardation) and neonatal toxicity (renal failure, hypotension, hyperkalaemia).
En tablet med 80 mg indeholder 338 mg sorbitol (E420).
Each 80 mg tablet contains 338 mg sorbitol (E420).
En tablet med 40 mg indeholder 169 mg sorbitol (E420).
Each 40 mg tablet contains 169 mg sorbitol (E420).
• hvis du samtidig tager et af følgende lægemidler til behandling af for højt blodtryk: - en ACE-hæmmer (f.eks. enalapril, lisinopril, ramipril), især hvis du har nyrerproblemer i forbindelse med sukkersyge - aliskiren Din læge vil eventuelt måle din nyrefunktion, dit blodtryk og elektrolytter (f.eks. kalium) i dit blod med jævne mellemrum.
• if you are taking any of the following medicines used to treat high blood pressure: - an ACE-inhibitor (for example enalapril, lisinopril, ramipril), in particular if you have diabetes-related kidney problems.
Povidon (K25), meglumin, natriumhydroxid, sorbitol (E420), magnesiumstearat.
Povidone (K25) Meglumine Sodium hydroxide Sorbitol (E420) Magnesium stearate.
Pritor er pakket i blisterpakninger med 14, 28, 30, 56, 90 eller 98 tabletter.
Pritor is available in blister packs containing 14, 28, 30, 56, 90 or 98 tablets.
Hyperkaliæmi kan være letal for ældre, for patienter med nedsat nyreinsufficiens, for diabetespatienter, for patienter i behandling med andre lægemidler, der kan øge kaliumniveauet og/eller for patienter med tilstødende komplikationer.
In the elderly, in patients with renal insufficiency, in diabetic patients, in patients concomitantly treated with other medicinal products that may increase potassium levels, and/or in patients with intercurrent events, hyperkalaemia may be fatal.
Hvide runde 2,5 mm tabletter, hvori firmaets logo og koden 50H er præget.
White round tablets of 2.5 mm engraved with the code number '50H' on one side and the company logo on the other side.
Pakningsstørrelser: Blister med 14, 28, 30, 56, 90, 98 eller 280 tabletter eller perforeret enkeltdosisblister med 28 x 1 tabletter.
Pack sizes: Blister with 14, 28, 30, 56, 90, 98 or 280 tablets or perforated unit dose blisters with 28 x 1 tablets.
LISTE OVER HJÆLPESTOFFER Indeholder sorbitol (E420).
This medicinal product contains sorbitol (E420).
INFORMATION I BRAILLE-SKRIFT Pritor 40 mg
INFORMATION IN BRAILLE Pritor 40 mg
Pritor indeholder:
What Pritor contains
Pritor er pakket i blisterpakninger med 14, 28, 30, 56, 90, 98 eller 280 tabletter eller enkeltdosisblisterpakning indeholdende 28 x 1 tabletter.
Pritor is available in blister packs containing 14, 28, 30, 56, 90, 98 or 280 tablets, or unit dose blister packs containing 28 x 1 tablets.
NAVN OG ADRESSE PÅ INDEHAVEREN AF MARKEDSFØRINGSTILLADELSEN Bayer AG
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER Bayer AG
Før ikke motorkøretøj, hvis du føler dig svimmel eller træt.
If you feel dizzy or tired, do not drive or operate machinery.
Den blodtrykssænkende virkning med Pritor kan blive mindre, hvis du samtidig tager medicin mod gigt og lette smerter (non-steroid antiinflammatorisk medicin (NSAID) såsom acetylsalicylsyre eller ibuprofen) eller kortikosteroider.
The effect of Pritor may be reduced when you take NSAIDs (non steroidal anti-inflammatory medicines, e.g. aspirin or ibuprofen) or corticosteroids.
MINDSTEKRAV TIL MÆRKNING PÅ BLISTER ELLER STRIP Alle ikke 7 styks blisterkort
MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS Any non 7 count blister
INFORMATION I BRAILLESKRIFT Pritor 20 mg
INFORMATION IN BRAILLE Pritor 20 mg
Hvis Pritor tages mere end 3 måneder henne i graviditeten, kan det forårsage alvorlige fosterskader (se afsnit Graviditet).
Pritor is not recommended in early pregnancy, and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used at that stage (see pregnancy section).
Bradykardi
Bradycardia Tachycardia
Pritor 40 mg og 80 mg tabletter
Pritor 40 mg and 80 mg tablets
Nedsat hæmoglobin, forhøjet urinsyre, forhøjede leverenzymer,
Haemoglobin decreased, blood uric acid increased, hepatic enzyme increased, blood creatine phosphokinase increased,
INFORMATION I BRAILLESKRIFT Pritor 80 mg
INFORMATION IN BRAILLE Pritor 80 mg
Som alternativ anbefales behandlingsregimer med bedre etablerede sikkerhedsprofiler ved amning, specielt ved amning af nyfødte og præmature spædbørn.
Because no information is available regarding the use of Pritor during breast-feeding, Pritor is not recommended and alternative treatments with better established safety profiles during breast-feeding are preferable, especially while nursing a newborn or preterm infant.
Pritor må ikke gives til patienter med kolestase, obstruktive galdelidelser eller svært nedsat leverfunktion (se pkt.
Pritor is not to be given to patients with cholestasis, biliary obstructive disorders or severe hepatic impairment (see section 4.3) since telmisartan is mostly eliminated with the bile.
• Nedsat blodtilstrømning til en eller begge nyrer (nyrearteriestenose)
• Renal artery stenosis (narrowing of the blood vessels to one or both kidneys).
En tablet indeholder 40 mg telmisartan.
Each tablet contains 40 mg telmisartan.
Sådan skal du tage Pritor
How to take Pritor
Pritor bruges også til at nedsætte risikoen for hjerte-kar-hændelser og blodprop i hjernen hos voksne, som har en forøget risiko.
Pritor is also used to reduce cardiovascular events (i.e. heart attack or stroke) in adults who are at risk because they have a reduced or blocked blood supply to the heart or legs, or have had a stroke or have high risk diabetes.
MINDSTEKRAV TIL MÆRKNING PÅ BLISTER ELLER STRIP 7 styk blisterkort
MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS Blister of 7 tablets
Udseende og pakningsstørrelser Pritor 20 mg tabletter er hvide runde tabletter, hvorpå firmaets logo og koden 50H er præget.
What Pritor looks like and contents of the pack Pritor 20 mg tablets are white, round and engraved with the code number '50H' on one side and the company logo on the other side.
• Leversygdom
• Liver disease.
Sepsis* (ofte kaldet “blodforgiftning”, en alvorlig infektion med en betændelsesreaktion i hele kroppen, som kan føre til døden), øget antal hvide blodlegemer (eosinofili), for få blodplader (trombocytopeni), alvorlige allergiske reaktioner (anafylaktisk reaktion), overfølsomhedsreaktioner (såsom udslæt, kløe, vejrtrækningsbesvær, hvæsende åndedræt, hævelser i ansigtet og lavt blodtryk), lave blodsukkerniveauer (hos sukkersygepatienter), nervøsitet, søvnighed, nedsat syn, hurtig hjerterytme (puls), mundtørhed, maveuro, smagsforstyrrelser, unormal leverfunktion (japanske patienter har større sandsynlighed for at få denne bivirkning), hurtigt indsættende hævelse af hals og slimhinder (angioødem), som kan være dødelig, eksem, hudrødme, nældefeber, alvorligt medicinudløst udslæt, ledsmerter, smerter i arme og ben, senesmerter, influenzalignende symptomer, nedsat hæmoglobin samt forhøjet urinsyre, forhøjede leverenzymer eller forhøjet kreatinkinase i blodet.
Sepsis* (often called "blood poisoning", is a severe infection with whole-body inflammatory response which can lead to death), increase in certain white blood cells (eosinophilia),low platelet count (thrombocytopenia), severe allergic reaction (anaphylactic reaction), allergic reaction (e.g. rash, itching, difficulty breathing, wheezing, swelling of the face or low blood pressure), low blood sugar levels (in diabetic patients), feeling anxious, somnolence, impaired vision, fast heart beat (tachycardia), dry mouth, upset stomach, taste disturbance (dysgeusia), abnormal liver function (Japanese patients are more likely to experience this side effect) , rapid swelling of the skin and mucosa which can also lead to death (angioedema also with fatal outcome), eczema (a skin disorder), redness of skin, hives (urticaria), severe drug rash, , joint pain (arthralgia), pain in extremity, tendon pain, flu-like-illness, decreased haemoglobin (a blood protein), increased levels of uric acid, increased hepatic enzymes or creatine phosphokinase in the blood.
• Medicin, som kan forhøje blodets indhold af kalium, såsom kaliumholdige saltsubstitutter, kaliumbesparende medicin (visse typer vanddrivende tabletter) ACE-hæmmere, angiotensin IIreceptorantagonister, non steroide antiinflammatoriske medicintyper (NSAID´er som acetylsalicylsyre og ibuprofen), heparin, lægemidler der undertrykker immunsystemet (som ciclosporin og tacrolimus) samt antibiotika indeholdende trimethoprim.
• Medicines that may increase blood potassium levels such as salt substitutes containing potassium, potassium-sparing diuretics (certain 'water tablets'), ACE inhibitors, angiotensin II receptor antagonists, NSAIDs (non steroidal anti-inflammatory medicines, e.g. aspirin or ibuprofen), heparin, immunosuppressives (e.g. cyclosporin or tacrolimus), and the antibiotic trimethoprim.
Urinvejsinfektion, infektion i de øvre luftveje (som ondt i halsen, bihulebetændelse, almindelig forkølelse), blodmangel (anæmi), forhøjet kaliumindhold i blodet, besvær med at falde i søvn, tristhed (depression), besvimelse, svimmelhed, langsom puls (bradykardi), lavt blodtryk (hypotension) hos patienter i behandling for forhøjet blodtryk, svimmelhed når man rejser sig op (ortostatisk hypotension), stakåndethed, hoste, mavesmerter, diaré, maveubehag, oppustethed, opkastning, kløe, svedtendens, medicinudløst udslæt, rygsmerter, muskelkramper, muskelsmerter, nedsat nyrefunktion herunder akut nyresvigt, brystsmerter, træthedsfølelse og forhøjet kreatininniveau i blodet.
Urinary tract infections, upper respiratory tract infections (e.g. sore throat, inflamed sinuses, common cold), deficiency in red blood cells (anaemia), high potassium levels, difficulty falling asleep, feeling sad (depression), fainting (syncope), feeling of spinning (vertigo), slow heart rate (bradycardia), low blood pressure (hypotension) in users treated for high blood pressure, dizziness on standing up (orthostatic hypotension), shortness of breath, cough, abdominal pain, diarrhoea, discomfort in the abdomen, bloating, vomiting, itching, increased sweating, drug rash, back pain, muscle cramps, muscle pain (myalgia), kidney impairment including acute kidney failure, pain in the chest, feeling of weakness, and increased level of creatinine in the blood.
Udseende og pakningsstørrelser Pritor 40 mg tabletter er hvide aflange tabletter, hvorpå koden 51H er præget.
What Pritor looks like and contents of the pack Pritor 40 mg tablets are white, oblong-shaped and engraved with the code '51H' on one.
Pritor 40 mg tabletter
Pritor 40 mg tablets
Hvide aflange 3,8 mm tabletter, hvori koden 51H er præget.
Pritor 40 mg tablets White oblong tablets of 3.8 mm engraved with the code number '51H' on one side.
Der er rapporteret reversible stigninger i serum-lithiumkoncentrationerne samt toksicitet ved samtidig behandling med lithium og ACE-hæmmere.
Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with angiotensin converting enzyme inhibitors, and with angiotensin II receptor antagonists, including telmisartan.
I prækliniske studier blev der ikke påvist nedsat fertilitet hos hunner eller hanner ved brug af telmisartan.
In preclinical studies, no effects of Pritor on male and female fertility were observed.
Sepsis* (ofte kaldet "blodforgiftning", en alvorlig infektion med betændelsesreaktion i hele kroppen) eller hurtig hævelse af hud og slimhinder (angioødem).
Sepsis* (often called "blood poisoning", is a severe infection with whole-body inflammatory response), rapid swelling of the skin and mucosa (angioedema); these side effects are rare may affect up to 1 in 1,000 people) but are extremely serious and patients should stop taking the medicine and see their doctor immediately.
En tablet indeholder 20 mg telmisartan.
Each tablet contains 20 mg telmisartan.
Lægemidler, der kan udløse hyperkaliæmi er kaliumholdige saltsubstitutter, kaliumbesparende diuretika, ACE-hæmmere, angiotensin II-receptorantagonister, non steroide antiinflammatoriske lægemidler (NSAIDs, herunder selektive COX-2-hæmmere), heparin, immunosuppressiva (cyclosporin eller tacrolimus) og trimethoprim.
Medicinal products or therapeutic classes of medicinal products that may provoke hyperkalaemia are salt substitutes containing potassium, potassium-sparing diuretics, ACE inhibitors, angiotensin II receptor antagonists, non steroidal anti-inflammatory medicinal products (NSAIDs, including selective COX-2 inhibitors), heparin, immunosuppressives (cyclosporin or tacrolimus), and trimethoprim.
En tablet indeholder 80 mg telmisartan.
Each tablet contains 80 mg telmisartan.
Metabolisme og ernæring Ikke almindelig:
Anaphylactic reaction, hypersensitivity Metabolism and nutrition disorders Uncommon: Rare:
I den første periode af behandlingen skal blodtrykket kontrolleres regelmæssigt.
At the beginning of the preventive therapy with Pritor 80 mg, blood pressure should be frequently monitored.
Udseende og pakningsstørrelser Pritor 80 mg tabletter er hvide aflange tabletter, hvorpå koden 52H er præget.
What Pritor looks like and contents of the pack Pritor 80 mg tablets are white, oblong-shaped and engraved with the code '52H' on one.
Pritor 20 mg tabletter
Pritor 20 mg tablets
Tabuleret liste over bivirkninger
Tabulated list of adverse reactions
Bradykardi, svimmelhed, øget serumkreatinin og akut nyresvigt er også set.
The most prominent manifestations of telmisartan overdose were hypotension and tachycardia; bradycardia, dizziness, increase in serum creatinine, and acute renal failure have also been reported.
Pritor 80 mg tabletter
Pritor 80 mg tablets
Hvide aflange 4,6 mm tabletter, hvori koden 52H er præget.
Pritor 80 mg tablets White oblong tablets of 4.6 mm engraved with the code number '52H' on one side.
Muligvis vil det være nødvendigt at stoppe brugen af anden medicin specielt, hvis det er noget af følgende:
In some cases you may have to stop taking one of the medicines.
ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Hver tablet indeholder 40 mg telmisartan.
STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains 40 mg telmisartan.
LÆGEMIDLETS NAVN Pritor 40 mg tabletter telmisartan
NAME OF THE MEDICINAL PRODUCT Pritor 40 mg tablets telmisartan
ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Hver tablet indeholder 20 mg telmisartan.
STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains 20 mg telmisartan.
LÆGEMIDLETS NAVN Pritor 80 mg tabletter telmisartan
NAME OF THE MEDICINAL PRODUCT Pritor 80 mg tablets telmisartan
Angioødem (også med letalt udfald), eksem, erytem, urticaria, medikamentelt udløst udslæt, toksisk hududslæt Knogler, led, muskler og bindevæv Ikke almindelig:
Pruritus, hyperhidrosis, , rash Angioedema (also with fatal outcome), eczema, erythema, urticaria, drug eruption, toxic skin eruption
Telmisartan er en angiotensin II-receptorantagonist.
Pritor belongs to a group of medicines known as angiotensin II receptor antagonists.
ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Hver tablet indeholder 80 mg telmisartan.
STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains 80 mg telmisartan.
EU/1/98/089/011 (14 tabletter) EU/1/98/089/012 (28 tabletter) EU/1/98/089/020 (30 tabletter) EU/1/98/089/013 (56 tabletter) EU/1/98/089/019 (90 tabletter) EU/1/98/089/014 (98 tabletter)
EU/1/98/089/011 (14 tablets) EU/1/98/089/012 (28 tablets) EU/1/98/089/020 (30 tablets) EU/1/98/089/013 (56 tablets) EU/1/98/089/019 (90 tablets) EU/1/98/089/014 (98 tablets)
LÆGEMIDLETS NAVN Pritor 20 mg tabletter telmisartan
NAME OF THE MEDICINAL PRODUCT Pritor 20 mg tablets telmisartan
Nedenstående kombinationer frarådes.
Concomitant use not recommended.
Dosis bør ikke overskride 40 mg hos patienter med let til moderat nedsat leverfunktion (se pkt.
In patients with mild to moderate hepatic impairment the posology should not exceed 40 mg once daily (see section 4.4).
Alternativt, kan telmisartan anvendes i kombination med et diuretikum af thiazidgruppen, såsom hydrochlorthiazid.
Alternatively, telmisartan may be used in combination with thiazide-type diuretics such as hydrochlorothiazide, which has been shown to have an additive blood pressure lowering effect with telmisartan.
Mht. det prædefinerede sekundære endepunkt (reduktion af kardiovaskulær død, ikke-letalt myokardieinfarkt og ikke-letal apopleksi) - som var identisk med det primære endepunkt i HOPEstudiet (The Heart Outcomes Prevention Evaluation Study) blev telmisartan fundet ligeværdig med ramipril [0,99 (97,5% CI 0,90-1,08, p (non-inferioritet) = 0,0004)].
Telmisartan was found to be similarly effective to ramipril in the pre-specified secondary endpoint of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke [0.99 (97.5 % CI 0.901.08), p (non-inferiority) = 0.0004], the primary endpoint in the reference study HOPE (The Heart Outcomes Prevention Evaluation Study), which had investigated the effect of ramipril vs. placebo.
• Obstruktive galdelidelser • Svært nedsat leverfunktion
• Biliary obstructive disorders
Indehaver af markedsføringstilladelsen Bayer AG
Marketing Authorisation Holder Bayer AG
Hud og subkutane væv Ikke almindelig:
Hepatic function abnormal/liver disorder Skin and subcutaneous tissue disorders Uncommon: Rare:
EU/1/98/089/001 (14 tabletter) EU/1/98/089/002 (28 tabletter) EU/1/98/089/021 (30 tabletter) EU/1/98/089/003 (56 tabletter) EU/1/98/089/017 (90 tabletter) EU/1/98/089/004 (98 tabletter) EU/1/98/089/005 (280 tabletter) EU/1/98/089/015 (28 x 1 tablet)
EU/1/98/089/001 (14 tablets) EU/1/98/089/002 (28 tablets) EU/1/98/089/021 (30 tablets) EU/1/98/089/003 (56 tablets) EU/1/98/089/017 (90 tablets) EU/1/98/089/004 (98 tablets) EU/1/98/089/005 (280 tablets) EU/1/98/089/015 (28 x 1 tablets)
EU/1/98/089/006 (14 tabletter) EU/1/98/089/007 (28 tabletter) EU/1/98/089/022 (30 tabletter) EU/1/98/089/008 (56 tabletter) EU/1/98/089/018 (90 tabletter) EU/1/98/089/009 (98 tabletter) EU/1/98/089/010 (280 tabletter) EU/1/98/089/016 (28 x 1 tablet)
EU/1/98/089/006 (14 tablets) EU/1/98/089/007 (28 tablets) EU/1/98/089/022 (30 tablets) EU/1/98/089/008 (56 tablets) EU/1/98/089/018 (90 tablets) EU/1/98/089/009 (98 tablets) EU/1/98/089/010 (280 tablets) EU/1/98/089/016 (28 x 1 tablets)
Disse fund synes ikke at være af signifikant klinisk betydning og anses også for at være klasseeffekter ved ACE-hæmmere og andre angiotensin II-receptorantagonister,.
These changes, also a class effect of angiotensin converting enzyme inhibitors and other angiotensin II receptor antagonists, do not appear to have clinical significance.